Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- A5183 ClopidogrelTarget: P2Y ReceptorsSummary: P2Y12 receptor antagonist
- A5220 Vecuronium BromideTarget: AChRSummary: Nonpolarizing neuromuscular relaxant
- A5294 Sumatriptan SuccinateTarget: 5-HT1 ReceptorsSummary: 5-HT1 receptor agonist
- A5350 Ziprasidone HClSummary: Serotonin and dopamine receptor antagonist
- A5391 Varenicline TartrateSummary: Subtype-selective agonist of α4β2 nicotinic receptors,orally active
- A5399 IloperidoneSummary: Dopamine (D2) and serotonin (5HT2) receptor antagonist
- A5791 Ibuprofen LysineSummary: COX inhibitor
- A2623 VU 0364439Summary: Positive allosteric mGluR-4 modulator
- A2547 Vortioxetine (Lu AA21004) HBrSummary: 5-HT receptor modulator, antidepressant and anxiolytic
- A2098 PRX-08066 Maleic acidSummary: 5-HT2B receptor antagonist,potent and selective